Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAMSTA severe hypertension
2008-000873-40Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) comparing Telmisartan + amlodipine fixed-dose combination, Amlodipine monotherapy and Telmisartan monotherapy (3 arms). Started Nov 2008; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2008-000873-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000873-40.